• Kalysta@lemm.ee
    link
    fedilink
    English
    arrow-up
    7
    ·
    2 hours ago

    Bullshit take. Some people ONLY respond to insulin. Fuck whoever wrote this.

    • Sauerkraut@discuss.tchncs.de
      link
      fedilink
      English
      arrow-up
      1
      ·
      14 minutes ago

      I apologize if this sounds pedantic, but what if the writer was forced to write it to keep his job along with his family’s access to food, shelter, and healthcare? So rather than punch down, I say punch up. I say fuck the owners who ultimately signed off on the article and potentially demanded it in the first place. (The Atlantic is owned by Emerson Collective which is owned by billionaire Laurene Jobs. )

    • AeonFelis@lemmy.world
      link
      fedilink
      English
      arrow-up
      8
      arrow-down
      1
      ·
      3 hours ago

      This was not written by some reach asshole. This was written by someone on the payroll of some rich asshole.

      • Sauerkraut@discuss.tchncs.de
        link
        fedilink
        English
        arrow-up
        1
        ·
        8 minutes ago

        Yes! Without shared ownership over the companies we work at, we have no ownership over how our labor is used. This is why a worker owned economy is such a critical part of Marxism and why Social democracy’s attempt to achieve socialist goals through higher taxes and labor rights isn’t enough (a golden cage is still a cage.) The heart of socialism is giving people a shared ownership over their labor which means they get a voice and vote on how their labor will be used

  • dogsoahC@lemm.ee
    link
    fedilink
    English
    arrow-up
    26
    ·
    edit-2
    5 hours ago

    Have you read the article? It’s about how type 2 patients, for whom insulin isn’t the best option and who make up the majority of diabetes patients could end up having to use insulin because it’s cheaper.

    “In place of capping the out-of-pocket cost of just insulin, lawmakers should cap the out-of-pocket cost of all diabetes medications.”

    • GrumpyDuckling@sh.itjust.works
      link
      fedilink
      English
      arrow-up
      7
      arrow-down
      1
      ·
      4 hours ago

      A lot of type two patients need to manage their diets better. You wouldn’t believe the number of people who just keep eating like shit.

    • PyroNeurosis@lemmy.blahaj.zone
      link
      fedilink
      English
      arrow-up
      15
      ·
      6 hours ago

      for whom diabetes isn’t the best option and who make up the …

      I guess you meant to say “insulin is not the best option”? Because diabetes seems like a shit option all around.

      • dogsoahC@lemm.ee
        link
        fedilink
        English
        arrow-up
        7
        arrow-down
        1
        ·
        5 hours ago

        Shhh, now come and sweep yourself under that nice little carpet.

      • dogsoahC@lemm.ee
        link
        fedilink
        English
        arrow-up
        6
        ·
        5 hours ago

        I think the point is that insurances might not pay for the better options as willingly as they do now if there’s a cheaper option. But I understand too little of the US healthcare system to be completely sure.

        • RememberTheApollo_@lemmy.world
          link
          fedilink
          English
          arrow-up
          5
          ·
          edit-2
          5 hours ago

          The problems aren’t the treatments, the problems are still the assholes pricing the treatments that exacerbate issues with treatment affordability and selection.

  • magnetosphere@fedia.io
    link
    fedilink
    arrow-up
    34
    arrow-down
    1
    ·
    21 hours ago

    What’s worse - taking diabetes medication that’s somewhat outdated, or taking no diabetes medication at all?

    I’m not a doctor, but I bet I know the answer.

    • Apytele@sh.itjust.works
      link
      fedilink
      English
      arrow-up
      10
      ·
      edit-2
      13 hours ago

      Also most of those newer treatments treat either type 2 (diet / metabolism related) or are an adjunct therapy for a type 1 (genetic) who has also developed insulin resistance over time. With or without insulin resistance a type 1 isn’t making any insulin in their pancreas at ALL and is going to need to take manufactured insulin, whether by a syringe or with an artificial pancreas that needs to be filled with an insulin cartridge. For them a metabolism altering medication isn’t going to make their pancreas start producing insulin again, it’s just going to help their cells respond better to the insulin they still have to inject.

      People have gotten so used to conceptualizing diabetes as a “fat people” disease that they completely ignore the type 1 genetic diabetics who are actually the main users of insulin. Oh and most children with diabetes have type 1 (since it’s genetic) vs type 2 which can be managed with the fancier newer drugs is the “fat people” / diet related type, and most people don’t get that until they’re at least middle aged and have been eating garbage for decades. When people talk about insulin they act like they’re talking about adults who made a choice when most of your exclusively insulin dependent diabetics are gonna be type 1s who got it from genetics and have had it since childhood.

      We should absolutely be caring about people regardless of these moralistic fat shaming arguments but the kind of people saying it’s not a big deal that a month of insulin costs $500 are also usually the same people crying “think of the children!” and the raw hypocrisy of that just drives me fucking bonkers.

      • ZILtoid1991@lemmy.world
        link
        fedilink
        English
        arrow-up
        7
        ·
        14 hours ago

        yOu juSt hAve To cuT swEetS, maYBe tRY tHe CArniVorE DieT

        - them actually

        Other times they’ll just advise you to use honey, because they think that’s not sugar.

  • Catoblepas@lemmy.blahaj.zone
    link
    fedilink
    English
    arrow-up
    52
    ·
    22 hours ago

    Hmm, who is this Rose fellow?

    Michael Rose is a senior resident in internal medicine and pediatrics at Johns Hopkins University School of Medicine.

    The only person The Atlantic could find to peddle this shit isn’t even allowed to practice medicine without supervision? lmao

    • Apytele@sh.itjust.works
      link
      fedilink
      English
      arrow-up
      5
      ·
      13 hours ago

      Not even an endocrine doctor. IM knows diabetic medicine because they happen to run into it a fair amount, along with a lot of other diseases from a lot of other body systems like kidney disease or COPD, but they’re not nephrologists or pulmonologists either.

    • Umbrias@beehaw.org
      link
      fedilink
      English
      arrow-up
      4
      ·
      15 hours ago

      credit to michael rose, they want all diabetes medications to be cheaper or free.

      • Catoblepas@lemmy.blahaj.zone
        link
        fedilink
        English
        arrow-up
        3
        ·
        edit-2
        14 hours ago

        That’s fair! It’s entirely possible they got rolled by The Atlantic and didn’t know what the editors were going to do to the piece. But like, at the same time maybe question why a national publication would need someone who isn’t able to practice on their own to do an opinion piece about something highly politicized… (them before they agreed to write the piece I mean, if that wasn’t clear)

        • Umbrias@beehaw.org
          link
          fedilink
          English
          arrow-up
          4
          ·
          6 hours ago

          another comment pointed out elsewhere that the titles are rarely made by the writer, so im inclined to believe that the atlantic recieved this piece and wanted to slant it for those who just read the headline, yeah.

    • evasive_chimpanzee@lemmy.world
      link
      fedilink
      English
      arrow-up
      66
      ·
      1 day ago

      The point it seems like they are trying to make (and I have only read up till the paywall) is that there are multiple forms of insulin, and newer versions basically work better. Many people are getting the newer, better drugs, but having to ration them because of how expensive they are. If plain, old insulin becomes cheap enough such that people switch to it (critically, without some extra effort by our healthcare system), a percentage of people will end up dying. Managing diabetes is all about keeping blood glucose stable, and that is asier to do with the modern stuff.

      They retitled the article to “Making Insulin Cheaper Isn’t Enough”, which i think is a much better headline.

      And again, I could only read up till the paywall, so i could be giving them too much credit.

      • dogsoahC@lemm.ee
        link
        fedilink
        English
        arrow-up
        2
        ·
        12 hours ago

        I didn’t have a paywall for some reason, so here’s the gist of it:

        Insulin is only the first choice for type 1 diabetes. For type 2, there are alternatives (not just variants of insulin, but actually different drugs) with fewer side effects, and which are more effective against the serious dangers like heart attacks. But when insulin gets much cheaper, those patients (i.e. the majority of diabetes patients) could end up using insulin and run a higher risk of those more deadly symptoms. Towards the end, the article even says: “In place of capping the out-of-pocket cost of just insulin, lawmakers should cap the out-of-pocket cost of all diabetes medications.”

      • takeda@lemm.ee
        link
        fedilink
        English
        arrow-up
        1
        ·
        12 hours ago

        Maybe that would motivate pharmaceutical companies to work on treatments that actually cure diabetes?

        Seems like are breakthrough treatments we are getting over recent years is just to manage the sickness.

      • Shirasho@lemmings.world
        link
        fedilink
        English
        arrow-up
        39
        ·
        1 day ago

        The fact they changed the headline is itself praiseworthy, but the fact it was click bait and sensationalist to begin counters it.

        The point about making the older stuff cheaper is something that isn’t mentioned as much as it should be in these debates.

        Ultimately even if the older stuff is worse and requires more attention and monitoring (less convenient), it is still better than nothing.

        • evasive_chimpanzee@lemmy.world
          link
          fedilink
          English
          arrow-up
          18
          ·
          1 day ago

          Someone posted a link to the full text. Looks like their main point is that for most people with diabetes (who have type 2), insulin of any form isn’t the best first line treatment, things like glp-1 receptor agonists (e.g., ozempic) work way better, but since it’s not “insulin” it’s not covered.

          I’m guessing the editors of the Atlantic gave it the original bad headline, cause it seems like the author is genuine.

          • luciferofastora@lemmy.zip
            link
            fedilink
            English
            arrow-up
            6
            ·
            15 hours ago

            So the physician cares about patient wellbeing while the newspaper cares about engagement? Sounds about right

      • dmention7@lemm.ee
        link
        fedilink
        English
        arrow-up
        8
        ·
        edit-2
        1 day ago

        “Making Insulin Cheaper Isn’t Enough” sounds like a good headline on its own, but with the context of the original headline and tagline, it sure sounds like the rest of the article is going to be making point for not making insulin cheaper at all.

        Maybe there is a real call to action buried past the paywall, but I don’t see it, and therefore I can only assume that what I can see without paying is the message they want to push.

        • evasive_chimpanzee@lemmy.world
          link
          fedilink
          English
          arrow-up
          13
          ·
          1 day ago

          Someone posted a link to the full text. Looks like their main point is that for most people with diabetes (who have type 2), insulin of any form isn’t the best first line treatment, things like glp-1 receptor agonists (e.g., ozempic) work way better, but since it’s not “insulin” it’s not covered.

          I’m guessing the editors of the Atlantic gave it the original bad headline, cause it seems like the author is genuine.

          • dmention7@lemm.ee
            link
            fedilink
            English
            arrow-up
            2
            ·
            21 hours ago

            That makes more sense, I suppose.

            Still seems like an odd article choice since type 1 and 2 diabetes are totally separate diseases with different causes and treatments. So of course reducing insulin prices won’t do anything to help type 2 diabetics.

  • Cheems@lemmy.world
    link
    fedilink
    English
    arrow-up
    33
    ·
    1 day ago

    If diabetics get insulin for free they’d become dependent and require it for the rest of their lives. It’s safer to just let them die or leave them homeless because they have to spend all their money on it.

    /s

  • usernamesAreTricky@lemmy.ml
    link
    fedilink
    English
    arrow-up
    45
    ·
    edit-2
    1 day ago

    The title of the article is clickbait/ragebait. The actual article content is a little different. The gist of it is more so this:

    In place of capping the out-of-pocket cost of just insulin, lawmakers should cap the out-of-pocket cost of all diabetes medications.

    https://archive.is/tvVHP

    Headline writters are often/usually different people than the person who wrote the article leading to infuriating things like this

    • Phoenixz@lemmy.ca
      link
      fedilink
      English
      arrow-up
      12
      ·
      1 day ago

      Yeah well in this case it basically means that the headline is absolute bullshit. It might as well have said something about puppies.

      News organizations should be held to higher standards here, and be honest ffs

    • JaggedRobotPubes@lemmy.world
      link
      fedilink
      English
      arrow-up
      1
      ·
      19 hours ago

      Whatever the reason for the amateur bullshit, it’s amateur bullshit on the part of the atlantic, which is the actual headline here.

  • drdalek@lemmy.dbzer0.com
    link
    fedilink
    English
    arrow-up
    13
    arrow-down
    1
    ·
    1 day ago

    This only makes sense if the new treatments are cheaper or free than insulin. Which I’d bet a body part they aren’t.